Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
US Vice President Vance warns UK against increasing censorship, drawing parallels with free speech concerns in the US.
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
US Vice President Vance warns UK against increasing censorship, drawing parallels with free speech concerns in the US.